Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
Large-scale molecular profiling and genotyping provide a unique opportunity to systematically compare the genetically predicted effects of therapeutic targets on the human metabolome. We firstly constructed genetic risk scores for 8 drug targets on the basis that they primarily modify low-density li...
Saved in:
| Main Authors: | Tom G Richardson, Genevieve M Leyden, Qin Wang, Joshua A Bell, Benjamin Elsworth, George Davey Smith, Michael V Holmes |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2022-02-01
|
| Series: | PLoS Biology |
| Online Access: | https://journals.plos.org/plosbiology/article/file?id=10.1371/journal.pbio.3001547&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis.
by: Tom G Richardson, et al.
Published: (2020-03-01) -
A lifecourse mendelian randomization study highlights the long-term influence of childhood body size on later life heart structure.
by: Katie O'Nunain, et al.
Published: (2022-06-01) -
Distinct pathway-based effects of blood pressure and body mass index on cardiovascular traits: comparison of novel Mendelian randomization approaches
by: Genevieve M. Leyden, et al.
Published: (2025-05-01) -
Influence of puberty timing on adiposity and cardiometabolic traits: A Mendelian randomisation study.
by: Joshua A Bell, et al.
Published: (2018-08-01) -
Metabolomic characterisation of the glioblastoma invasive margin reveals a region-specific signature
by: James Wood, et al.
Published: (2025-01-01)